167 related articles for article (PubMed ID: 38285784)
1. Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra.
Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
[TBL] [Abstract][Full Text] [Related]
2. Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients:A Study from South-Western Maharashtra.
Gudur AK; Gudur RA; Bhosale SJ; Kale SR; Datkhile KD
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3049-3057. PubMed ID: 37774056
[TBL] [Abstract][Full Text] [Related]
3. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
[TBL] [Abstract][Full Text] [Related]
4. The Role of DNA Repair (
Crișan AS; Tripon F; Bogliș A; Crauciuc GA; Trifa AP; Lázár E; Macarie I; Gabor MR; Bănescu C
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541232
[No Abstract] [Full Text] [Related]
5. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract][Full Text] [Related]
8. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
[TBL] [Abstract][Full Text] [Related]
9. Risk Modulation of Oral Pre Cancer and Cancer with Polymorphisms in XPD and XPG Genes in North Indian Population.
Nigam K; Yadav SK; Samadi FM; Bhatt ML; Gupta S; Sanyal S
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2397-2403. PubMed ID: 31450912
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
12. DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in XPC and XPD genes modulate DNA damage in pesticide-exposed agricultural workers of Punjab, North-West India.
Kaur K; Kaur R
Mol Biol Rep; 2020 Jul; 47(7):5253-5262. PubMed ID: 32562175
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
15. Are XPD and XPG gene variants related to the mechanism of oral squamous cell carcinoma?
Avci H; Iplik ES; Aydemir L; Acar S; Kiyak E; Unur M; Cakmakoglu B
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):94-99. PubMed ID: 30672443
[TBL] [Abstract][Full Text] [Related]
16. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.
Das S; Bhowmik A; Bhattacharjee A; Choudhury B; Naiding M; Laskar AK; Ghosh SK; Choudhury Y
Tumour Biol; 2015 Sep; 36(10):7569-79. PubMed ID: 25916209
[TBL] [Abstract][Full Text] [Related]
17. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
[TBL] [Abstract][Full Text] [Related]
18. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
19. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
20. XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Lopes-Aguiar L; Costa EF; Nogueira GA; Lima TR; Visacri MB; Pincinato EC; Calonga L; Mariano FV; de Almeida Milani Altemani AM; Altemani JM; Coutinho-Camillo CM; Ribeiro Alves MA; Moriel P; Ramos CD; Chone CT; Lima CS
Oncotarget; 2017 Mar; 8(10):16190-16201. PubMed ID: 26918827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]